Ablynx is granted GLP certificate for new GLP unit
Ablynx announced that it has been granted a Certificate of Good Laboratory Practise (GLP) from the Belgian Scientific Institute of Public Health (IPH) for its new GLP unit at its headquarters in Ghent, Belgium, after having been inspected in May 2011.
Having received this GLP certificate, Ablynx's GLP unit will be able to seamlessly carry out pre-clinical analytical testing and pharmacokinetics studies in-house, to the required regulatory standard.
Dr Edwin Moses, CEO and Chairman of Ablynx, commented: "Being awarded the GLP certificate from the Belgian authorities confirms our commitment to consistently perform at a high standard in this stringent regulatory environment. This is an important milestone for Ablynx as we continue to grow towards a product-based company. With this certificate, we no longer solely rely on third parties to carry out the pre-clinical GLP testing for our programmes. This enables us to retain more control on quality, timing and associated costs."
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
